Dna Repair Deficient Or Platinum Sensitive Solid Tumors clinical trials

Explore recruiting dna repair deficient or platinum sensitive solid tumors clinical trials.

Also recruiting in Europe

Dna Repair Deficient Or Platinum Sensitive Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open label phase II basket trial exploring the efficacy and safety of the combination of Niraparib and Dostarlimab in patients with DNA repair-deficient or platinum-sensitive solid tumors (NIRADO)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Dna Repair Deficient Or Platinum Sensitive Solid Tumors trials by city

Dna Repair Deficient Or Platinum Sensitive Solid Tumors in Toronto Dna Repair Deficient Or Platinum Sensitive Solid Tumors in Vancouver Dna Repair Deficient Or Platinum Sensitive Solid Tumors in Montreal Dna Repair Deficient Or Platinum Sensitive Solid Tumors in Calgary Dna Repair Deficient Or Platinum Sensitive Solid Tumors in Edmonton Dna Repair Deficient Or Platinum Sensitive Solid Tumors in Ottawa Dna Repair Deficient Or Platinum Sensitive Solid Tumors in Winnipeg Dna Repair Deficient Or Platinum Sensitive Solid Tumors in Quebec City Dna Repair Deficient Or Platinum Sensitive Solid Tumors in Hamilton Dna Repair Deficient Or Platinum Sensitive Solid Tumors in Kitchener Dna Repair Deficient Or Platinum Sensitive Solid Tumors in London Dna Repair Deficient Or Platinum Sensitive Solid Tumors in Halifax Dna Repair Deficient Or Platinum Sensitive Solid Tumors in New York Dna Repair Deficient Or Platinum Sensitive Solid Tumors in Los Angeles Dna Repair Deficient Or Platinum Sensitive Solid Tumors in Chicago Dna Repair Deficient Or Platinum Sensitive Solid Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease